Clinical Trials | January 11, 2026
Merck initiates phase 3 trial of calderasib with Keytruda QLEX for NSCLC
KRAS G12C-mutant advanced or metastatic nonsquamous non-small cell lung cancer
KRAS G12C-mutant advanced or metastatic nonsquamous non-small cell lung cancer
The current two-vial format requires healthcare professionals to mix a lyophilised antigen with a liquid adjuvant before administration
NTX-253 is a potent, selective, orally available positive allosteric modulator (PAM) of the muscarinic M4 receptor
This product has only one approved generic and one authorized generic with an addressable market share of US$ 172 million
The approval is backed by data showing deep, durable responses and manageable tolerability
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation
The approval follows robust data from the SWIFT and ANCHOR Phase III trials
The MAGiC catheter is designed for robotically-navigated cardiac ablation procedures
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
It is currently the only vaccine authorized by the Drug Controller General of India (DCGI) for active immunization against HEV in adults aged 18 to 65
Subscribe To Our Newsletter & Stay Updated
